Maurizio Della Pietra
Particle Measuring Systems Inc
Global PLM Automation & Advisory
Maurizio Della Pietra has experience in pharmaceutical validation and sterility assurance.
He earned his Master's Degree in Physics with a thesis regarding an electronic trigger for measuring Supernova neutrinos for an international experiment.
His experience in the pharmaceutical field started in 2006 in a consultancy company as a computer system validation and compliance specialist.
From 2009 to 2017, he worked as Validation and Sterility Assurance Manager for a pharmaceutical company that produces freeze-dried and liquid sterile drug products derived from human plasma.
During these years, he improved his knowledge about QA processes, validation of equipment, utilities, facilities, computer systems, data, and production processes, and above all, he gained experience in aseptic production processes and statistical analysis of them.
Today Maurizio is the Product Line Manager, Automation, and Advisory. In this role, he collaborates with pharmaceutical companies and developers of pharmaceutical equipment and isolation technologies to improve the sterility assurance of science-based strategies.
He earned his Master's Degree in Physics with a thesis regarding an electronic trigger for measuring Supernova neutrinos for an international experiment.
His experience in the pharmaceutical field started in 2006 in a consultancy company as a computer system validation and compliance specialist.
From 2009 to 2017, he worked as Validation and Sterility Assurance Manager for a pharmaceutical company that produces freeze-dried and liquid sterile drug products derived from human plasma.
During these years, he improved his knowledge about QA processes, validation of equipment, utilities, facilities, computer systems, data, and production processes, and above all, he gained experience in aseptic production processes and statistical analysis of them.
Today Maurizio is the Product Line Manager, Automation, and Advisory. In this role, he collaborates with pharmaceutical companies and developers of pharmaceutical equipment and isolation technologies to improve the sterility assurance of science-based strategies.